Betahistine Hydrochloride Market: Rising Demand for Vertigo and Meniere's Disease Treatments, Expanding Inner Ear Disorder Therapies, and Growing Global Access to Vestibular Medications Driving Market Growth
The Betahistine Hydrochloride Market is experiencing steady growth as the prevalence of Meniere's disease and other inner ear disorders increases globally. The market was estimated at approximately USD 500 million in 2025 and is projected to grow at a CAGR of around 6% from 2025 to 2033. This growth reflects the continued use of betahistine as a first-line therapy for vertigo, tinnitus, and...
0 Comentários 0 Compartilhamentos 83 Visualizações 0 Anterior